查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1304299

癌症治療藥市場:各藥物類別類型，各適應症，各地區:市場規模，佔有率，展望，機會分析，2023年～2030年

Cancer Drugs Market, By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy) and By Indication By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態:

癌症患病率的增加、老年人口的增加、對安全有效的抗癌藥物的高需求、人們對癌症和抗癌藥物的認識不斷提高以及癌症治療中心數量的增加，預計將在2019年促進全球抗癌藥物市場的增長。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球癌症治療藥市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球癌症治療藥市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球癌症治療藥市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球癌症治療藥市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • 連貫·機遇·地圖(COM)

第3章 市場動態，法規，趨勢分析

  • 市場動態
    • 全球癌症負擔日益增加
    • 抗癌藥物的不良反應
    • 對安全有效藥物的需求不斷增長
  • 影響分析
  • 主要的焦點
  • 法規情勢
  • 產品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收購情勢

第4章 全球癌症治療藥市場-冠狀病毒(COVID-19)大流行病的影響

  • COVID-19流行病學
  • 供給面和需求面的分析
  • 經濟影響

第5章 癌症治療藥的全球市場:各藥物類別類型，2023-2030年

  • 化療
  • 標靶治療
  • 荷爾蒙療法

第6章 癌症治療藥的全球市場，各適應症，2023-2030年

  • 簡介
  • 肺癌症
  • 胃癌
  • 大腸癌症
  • 乳癌
  • 前列腺癌症
  • 肝臟癌症
  • 食道癌症
  • 子宮頸癌症
  • 腎臟癌症
  • 膀胱癌
  • 其他的癌症

第7章 癌症治療藥的全球市場，各地區，2023年～2030年

  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Celgene Corporation
  • AstraZeneca PLC
  • Astellas Pharma Inc.
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson(Janssen Global Services, LLC)

第9章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5888

Cancer is a most lethal disease in which some of the body's cells grow uncontrollably and spread to other parts of the body. Cancer drugs, such as chemotherapy, hormone therapies, targeted cancer drugs, immunotherapy drugs, and bisphosphonates, among others, are used to treat different types of cancer. Thus, with the rise in burden of cancer, the demand for safe and effective cancer drugs is also increasing with a rapid pace, worldwide.

Market Dynamics:

Increasing prevalence of cancer, growing geriatric population, high demand for safe and effective cancer drugs, increasing awareness among people about a cancer and cancer drugs, and increasing number of cancer treatment centres are factors expected to augment the growth of the global cancer drugs market during the forecast period.

For instance, according to the American Cancer Society (ACS), in 2023, more than 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. While, in 2022, around 1.9 Billion new cancer cases and 609,360 cancer deaths were projected to occur in the U.S. Moreover, according to the cancer report by Indian Council of Medical Research (ICMR), India's cancer cases could increase by 12% in the next five years, with around 1.5 Billion people projected to suffer from the non-communicable disease by 2025, up from 1.39 Billion in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global cancer drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cancer drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co., Inc., Celgene Corporation, AstraZeneca PLC, Astellas Pharma Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, and Johnson & Johnson (Janssen Global Services, LLC), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer drugs market.

Detailed Segmentation:

  • Global Cancer Drugs Market, By Drug Class Type:
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy (Biologic Therapy)
    • Hormonal Therapy)
  • Global Cancer Drugs Market, By Indication:
    • Lung Cancer
    • Stomach Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Esophagus Cancer
    • Cervical Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Other Cancer
  • Global Cancer Drugs Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • Celgene Corporation
    • AstraZeneca PLC
    • Astellas Pharma Inc.
    • AbbVie Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bristol-Myers Squibb Company
    • Johnson & Johnson (Janssen Global Services, LLC)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing burden of cancer across the globe
    • Adverse effects of cancer drugs
    • Growing demand for safe and effective drugs
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cancer Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cancer Drugs Market, By Drug Class Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
    • Immunotherapy (Biologic Therapy)
  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Hormonal Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Cancer Drugs Market, By Indication, 2023-2030, (US$ Bn)

  • Intzroduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Stomach Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Esophagus Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Kidney Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Bladder Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cancer Drugs Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Bn)

8. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celgene Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson (Janssen Global Services, LLC)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us